Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;34:309-314

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fletcher, E. C.
Right arrow Articles by Li, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fletcher, E. C.
Right arrow Articles by Li, R.
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Animal models of human disease
Right arrow Hypertension - basic studies
Right arrow Other etiology

(Hypertension. 1999;34:309-314.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Renin Activity and Blood Pressure in Response to Chronic Episodic Hypoxia

Eugene C. Fletcher; Gang Bao; Rena Li

From the Department of Medicine, Division of Respiratory, Environmental and Critical Care Medicine, Louisville Veterans Affairs Medical Center and the University of Louisville School of Medicine, Louisville, Ky.

Correspondence to Eugene C. Fletcher, MD, Professor of Medicine, Division of Respiratory, Critical Care and Environmental Medicine, University of Louisville School of Medicine, Ambulatory Care Building, Room A3L01, 530 S Jackson St, Louisville, KY 40292.

Abstract—Previous studies in several strains of rats have demonstrated that 35 days of recurrent episodic hypoxia (EH) (7 hours per day), with a fractional concentration of inspired oxygen that produces desaturation equivalent to the recurrent hypoxemia of sleep apnea, results in an 8 to 13 mm Hg persistent increase in diurnal systemic blood pressure (BP). Carotid chemoreceptors and the sympathetic nervous system have been shown to be necessary for development of this BP increase. Both renal artery denervation and adrenal demedullation block the BP response to chronic EH. The present study was undertaken to define further the role of the kidneys and the renin-angiotensin system in this BP increase. Separate groups of male Sprague-Dawley rats had either (1) bilateral renal artery denervation with EH, (2) sham surgery with EH, (3) sham surgery with sham EH (compressed air), (4) EH with losartan, (5) unhandled with losartan, or (6) unhandled. The experimental period lasted 35 days. Both renal-artery denervated and losartan-treated animals showed no BP change or a lowering of BP in response to EH, whereas the sham-operated EH animals showed a progressive, sustained increase in resting room air BP. BP remained at basal levels or fell in unhandled and unhandled losartan-treated animals. Plasma renin activity was elevated 4-fold versus basal levels in EH animals with renal nerves intact but remained at baseline levels in denervated animals. At the end of the experiment, renal tissue catecholamines confirmed renal denervation in those animals. In conclusion, EH causes a progressive increase in BP, mediated in part through renal sympathetic nerve activity that acts to increase renin-angiotensin system activity through angiotensin II type 1 receptors.


Key Words: hypoxia • blood pressure • denervation, renal • sympathetic nervous system • sleep apnea syndromes • hypertension, systemic • renin-angiotensin system




This article has been cited by other articles:


Home page
J. Physiol.Home page
G. E. Foster, J. V. Brugniaux, V. Pialoux, C. T. C. Duggan, P. J. Hanly, S. B. Ahmed, and M. J. Poulin
Cardiovascular and cerebrovascular responses to acute hypoxia following exposure to intermittent hypoxia in healthy humans
J. Physiol., July 1, 2009; 587(13): 3287 - 3299.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P. Levy, J-L. Pepin, C. Arnaud, R. Tamisier, J-C. Borel, M. Dematteis, D. Godin-Ribuot, and C. Ribuot
Intermittent hypoxia and sleep-disordered breathing: current concepts and perspectives
Eur. Respir. J., October 1, 2008; 32(4): 1082 - 1095.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. J. Allahdadi, T. W. Cherng, H. Pai, A. Q. Silva, B. R. Walker, L. D. Nelin, and N. L. Kanagy
Endothelin type A receptor antagonist normalizes blood pressure in rats exposed to eucapnic intermittent hypoxia
Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H434 - H440.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
K. K. Gaddam, M. K. Nishizaka, M. N. Pratt-Ubunama, E. Pimenta, I. Aban, S. Oparil, and D. A. Calhoun
Characterization of Resistant Hypertension: Association Between Resistant Hypertension, Aldosterone, and Persistent Intravascular Volume Expansion
Arch Intern Med, June 9, 2008; 168(11): 1159 - 1164.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
T. V. Serebrovskaya, E. B. Manukhina, M. L. Smith, H. F. Downey, and R. T. Mallet
Intermittent Hypoxia: Cause of or Therapy for Systemic Hypertension?
Experimental Biology and Medicine, June 1, 2008; 233(6): 627 - 650.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
B. A. Kuri, S. A. Khan, S.-A. Chan, N. R. Prabhakar, and C. B. Smith
Increased secretory capacity of mouse adrenal chromaffin cells by chronic intermittent hypoxia: involvement of protein kinase C
J. Physiol., October 1, 2007; 584(1): 313 - 319.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. Parati, C. Lombardi, and K. Narkiewicz
Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1671 - R1683.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
V. L. Cooper, M. W. Elliott, S. B. Pearson, C. M. Taylor, M. M. J. Mohammed, and R. Hainsworth
Cardiovascular Control: Daytime variability of baroreflex function in patients with obstructive sleep apnoea: implications for hypertension
Exp Physiol, March 1, 2007; 92(2): 391 - 398.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
W. T. McNicholas, M. R. Bonsignore, and the Management Committee of EU COST ACTION B26
Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities
Eur. Respir. J., January 1, 2007; 29(1): 156 - 178.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
D. B. Zoccal, L. G. H. Bonagamba, F. R. T. Oliveira, J. Antunes-Rodrigues, and B. H. Machado
Increased sympathetic activity in rats submitted to chronic intermittent hypoxia
Exp Physiol, January 1, 2007; 92(1): 79 - 85.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
G. E. Foster, M. J. Poulin, and P. J. Hanly
Sleep Apnoea & Hypertension: Physiological bases for a causal relation: Intermittent hypoxia and vascular function: implications for obstructive sleep apnoea
Exp Physiol, January 1, 2007; 92(1): 51 - 65.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
M. T. Pawlik, E. Hansen, D. Waldhauser, C. Selig, and T. S. Kuehnel
Clonidine Premedication in Patients with Sleep Apnea Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study
Anesth. Analg., November 1, 2005; 101(5): 1374 - 1380.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Hinojosa-Laborde and S. W. Mifflin
Sex Differences in Blood Pressure Response to Intermittent Hypoxia in Rats
Hypertension, October 1, 2005; 46(4): 1016 - 1021.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
L. Lin, L. Finn, J. Zhang, T. Young, and E. Mignot
Angiotensin-converting Enzyme, Sleep-disordered Breathing, and Hypertension
Am. J. Respir. Crit. Care Med., December 15, 2004; 170(12): 1349 - 1353.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. L. Goodfriend and D. A. Calhoun
Resistant Hypertension, Obesity, Sleep Apnea, and Aldosterone: Theory and Therapy
Hypertension, March 1, 2004; 43(3): 518 - 524.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. J. Cutler, N. M. Swift, D. M. Keller, W. L. Wasmund, and M. L. Smith
Hypoxia-mediated prolonged elevation of sympathetic nerve activity after periods of intermittent hypoxic apnea
J Appl Physiol, February 1, 2004; 96(2): 754 - 761.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. Y. Lam, M.-L. Fung, and P. S. Leung
Regulation of the angiotensin-converting enzyme activity by a time-course hypoxia in the carotid body
J Appl Physiol, February 1, 2004; 96(2): 809 - 813.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
K. M. Hla, J. B. Skatrud, L. Finn, M. Palta, and T. Young
The Effect of Correction of Sleep-Disordered Breathing on BP in Untreated Hypertension
Chest, October 1, 2002; 122(4): 1125 - 1132.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Thongboonkerd, E. Gozal, L. R. Sachleben Jr., J. M. Arthur, W. M. Pierce, J. Cai, J. Chao, M. Bader, J. B. Pesquero, D. Gozal, et al.
Proteomic Analysis Reveals Alterations in the Renal Kallikrein Pathway during Hypoxia-Induced Hypertension
J. Biol. Chem., September 13, 2002; 277(38): 34708 - 34716.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A. Elmasry, E. Lindberg, J. Hedner, C. Janson, and G. Boman
Obstructive sleep apnoea and urine catecholamines in hypertensive males: a population-based study
Eur. Respir. J., March 1, 2002; 19(3): 511 - 517.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
E. C. Fletcher, N. Orolinova, and M. Bader
Blood pressure response to chronic episodic hypoxia: the renin-angiotensin system
J Appl Physiol, February 1, 2002; 92(2): 627 - 633.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
Y. Tagaito, V. Y. Polotsky, M. J. Campen, J. A. Wilson, A. Balbir, P. L. Smith, A. R. Schwartz, and C. P. O'Donnell
A model of sleep-disordered breathing in the C57BL/6J mouse
J Appl Physiol, December 1, 2001; 91(6): 2758 - 2766.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. Xie, J. B. Skatrud, D. S. Puleo, and B. J. Morgan
Exposure to hypoxia produces long-lasting sympathetic activation in humans
J Appl Physiol, October 1, 2001; 91(4): 1555 - 1562.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. G. Ziegler, P. J. Mills, J. S. Loredo, S. Ancoli-Israel, and J. E. Dimsdale
Effect of Continuous Positive Airway Pressure and Placebo Treatment on Sympathetic Nervous Activity in Patients With Obstructive Sleep Apnea
Chest, September 1, 2001; 120(3): 887 - 893.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. R. Prabhakar, R. D. Fields, T. Baker, and E. C. Fletcher
Intermittent hypoxia: cell to system
Am J Physiol Lung Cell Mol Physiol, September 1, 2001; 281(3): L524 - L528.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
E. C. Fletcher
Physiological and Genomic Consequences of Intermittent Hypoxia: Invited Review: Physiological consequences of intermittent hypoxia: systemic blood pressure
J Appl Physiol, April 1, 2001; 90(4): 1600 - 1605.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. L. Kanagy, B. R. Walker, and L. D. Nelin
Role of Endothelin in Intermittent Hypoxia-Induced Hypertension
Hypertension, February 1, 2001; 37(2): 511 - 515.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
H. Kraiczi, J. Hedner, Y. Peker, and J. Carlson
Increased vasoconstrictor sensitivity in obstructive sleep apnea
J Appl Physiol, August 1, 2000; 89(2): 493 - 498.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
P. J. Blankestijn, G. Ligtenberg, I. H. H. T. Klein, and H. A. Koomans
Sympathetic overactivity in renal failure controlled by ACE inhibition: clinical significance
Nephrol. Dial. Transplant., June 1, 2000; 15(6): 755 - 758.
[Full Text] [PDF]